TB
Publications
- ePresentations
- ePresentations
- ePresentations
- “Living together with dementia”: Training programme for family caregivers – A study protocol
- Catechol-O-Methyltransferase (COMT): An Update on Its Role in Cancer, Neurological and Cardiovascular Diseases.
- Strength training rescues mitochondrial dysfunction in skeletal muscle of patients with myotonic dystrophy type 1
- [Investigation of Genetic Aetiology in Neurodegenerative Ataxias: Recommendations from the Group of Neurogenetics of Centro Hospitalar São João, Portugal].
- Small lymphocytic lymphoma associated with extensive myelopathy: Case report and review of the literature.
- A neurologist’s hard day’s work: Impact of inpatient neurology consultation in a tertiary hospital,O dia-a-dia de um Neurologista Hospitalar: Impacto das consultas internas de neurologia num hospital terciário
- Mitochondrial DNA disorders: From pathogenic variants to preventing transmission
- The impact of deep brain stimulation on health related quality of life and disease-specific disability in Meige Syndrome (MS)
- Cell division can accelerate the loss of a heteroplasmic mitochondrial DNA mutation in a mouse model of mitochondrial disease
- The best care for children with facioscapulohumeral dystrophy
- Introducing NCL-SM: A Fully Annotated Dataset of Images from Human Skeletal Muscle Biopsies
- A Neurologist's Hard Day's Work: Impact of Inpatient Neurology Consultation in a Tertiary Hospital.
- A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1)
- Interactions of mitochondrial and skeletal muscle biology in mitochondrial myopathy
- A stagewise response to mitochondrial dysfunction in mitochondrial DNA maintenance disorders
- Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1
- RNA toxicity versus GSK3B dysfunction in myotonic dystrophy type 1: an exploratory review of the literature
- AMO-02 (tideglusib) for the treatment of congenital and childhood onset myotonic dystrophy type 1